3rd Quarter - Report

ABBOTT LABORATORIES for ABBOTT LABORATORIES

Firm
Client
Income
—
Expenses
$1,790,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Proposals to reform domestic and international tax structures R & D Tax Credit, Controlled Foreign Corporation look-through

LobbyistCovered position, as disclosed
ROSEMARY T HAAS —
ELAINE R LEAVENWORTH —
KRISTEN DW MORRIS —
ADELE R WITENSTEIN —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); SENATE

Medicare/Medicaid MMM

Proposals to modify DMEPOS reimbursement in Medicare Medicare payment proposals

LobbyistCovered position, as disclosed
ROSEMARY T HAAS —
ELAINE R LEAVENWORTH —
KRISTEN DW MORRIS —
CYNTHIA B SENSIBAUGH —
ADELE R WITENSTEIN —

Contacted: Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Health Issues HCR

Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Public Law 110-293, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act Implemenation of S.3187, The Food and Drug Administration Safety and Innovation Act of 2012 S.27 Preserve Access to Affordable Generics Act H.R. 3497, The MODDERN Cures Act of 2011 H.R.6446, a bill to create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests Proposals to establish a system to improve pharmaceutical traceability

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 6446 (112th), S. 3187 (112th), S. 27 (112th), H.R. 3497 (112th)

Trade (domestic/foreign) TRD

Trade issues regarding the Trans-Pacific Partnership Agreement S.3285, A bill to authorize the extension of of nondiscriminatory treatment (normal trade relations treatment) to products of the Russian Federation. International Intellectual property protection

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JASON GROVE —
ELAINE R LEAVENWORTH —
KRISTEN DW MORRIS —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE; Securities & Exchange Commission (SEC)

Bills named: S. 3285 (112th)

Financial Institutions/Investments/Securities FIN

Implementation of Section 1502, Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010

LobbyistCovered position, as disclosed
ROSEMARY T HAAS —
ELAINE R LEAVENWORTH —
KRISTEN DW MORRIS —

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA)

Agriculture AGR

Initiatives regarding infant nutrition

LobbyistCovered position, as disclosed
CATHERINE FERGUSON —
ELAINE R LEAVENWORTH —
KRISTEN DW MORRIS —

Contacted: Securities & Exchange Commission (SEC); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA)

Budget/Appropriations BUD

Implementation of Public Law 112-25, The Budget Control Act of 2011 H.R.5973, Agriculture, Rural Development, Food and Drug Adminstration, and Related Agencies Appropriations Act, 2013

LobbyistCovered position, as disclosed
ELAINE R LEAVENWORTH —
KRISTEN DW MORRIS —
ADELE R WITENSTEIN —

Contacted: SENATE; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA)

Bills named: H.R. 5973 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.